drugset / Trial / NCT03843749
Pyrotinib in Combination With Trastuzumab in Treatment-refractory, HER2-positive Metastatic Colorectal Cancar.
NaSingle-groupOpen-labelTreatment
Summary
This clinical trial aims to evaluate the efficacy, safety of Pyrotinib in combination with trastuzumab in Treatment-refractory, HER2-positive Metastatic Colorectal Cancar.
Timeline
- Start
- 2019-07-01
- Primary completion
- 2019-07-01
- Completion
- 2022-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pyrotinib | Small molecule | — | — |
| Background | Trastuzumab | Monoclonal antibody | — | — |